Insulet (PODD) Gains from Sales and Divestitures (2010 - 2012)
Insulet (PODD) reported Gains from Sales and Divestitures of $238134.0 for Q4 2012, up 47.16% on a YoY basis from $161816.0 in Q1 2012, and up 18.59% quarter-over-quarter from $200812.0 in Q3 2012.
Insulet (PODD) Gains from Sales and Divestitures (2010 - 2012) Analysis & Trends
Insulet has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $238134.0 in Q4 2012.
- For the quarter ending Q4 2012, Gains from Sales and Divestitures rose 47.16% year-over-year to $238134.0; the trailing twelve-month figure through Dec 2012 stood at $238134.0 (up 47.16% YoY), and the FY2012 full-year result was $238134.0, up 47.16% from the prior year.
- Gains from Sales and Divestitures for Q4 2012 stood at $238134.0, up from $200812.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $238134.0 in Q4 2012, with the low at $1776.0 in Q4 2010.
- Historically, Gains from Sales and Divestitures has averaged $155834.8 across 3 years, with a median of $176480.5 in 2011.
- Annual changes were most pronounced in 2011 — Gains from Sales and Divestitures soared 9011.26% — and 2012, when it surged 47.16%.
- Insulet's Gains from Sales and Divestitures stood at $1776.0 in 2010, then soared by 9011.26% to $161816.0 in 2011, then soared by 47.16% to $238134.0 in 2012.
- The last three Gains from Sales and Divestitures figures came in at $238134.0 (Q4 2012), $200812.0 (Q3 2012), and $191145.0 (Q2 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 238,134.00 |
| Dec 31, 2012 | 238,134.00 |
| Sep 30, 2012 | 200,812.00 |
| Sep 30, 2012 | 200,812.00 |
| Jun 30, 2012 | 191,145.00 |
| Jun 30, 2012 | 191,145.00 |
| Mar 31, 2012 | 141,326.00 |
| Mar 31, 2012 | 141,326.00 |
| Dec 31, 2011 | 161,816.00 |
| Dec 31, 2011 | 161,816.00 |
| Dec 31, 2010 | 1,776.00 |
| Dec 31, 2010 | 1,776.00 |